Health Condition 1: C029- Malignant neoplasm of tongue, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Early oral cancer (cT1 and T2) â?? biopsy proven 2. Patient planned for upfront surgery 3. Clinically N0 Neck 4. Willing to participate in the study
Exclusion criteria
Exclusion criteria: 1. Recurrent oral cavity cancer or second primary oral cavity tumour 2. Tumor within two centimetres of the midline 3. History of prior radiation to head and neck region 4. Allergy to the dye 5. Presence of major co-morbidities making the patient unfit for surgery 6. Any past history extensive surgery in the oral cavity or in neck which might have resulted in the disruption of lymphatics 7. Pregnant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the feasibility of SLNB in the management of early oral cavity cancer using combined blue dye and radiotracer technique.Timepoint: september 2021 | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the Sensitivity, specificity, negative predictive value, positive predictive value and accuracy of SLNB in oral cancer using radioactive tracer and blue dye alone versus combined method Timepoint: 24 months; To compare the diagnostic accuracy of frozen section examination with paraffin section examination of sentinel nodes Timepoint: 24 months; To estimate the Sensitivity, specificity, negative predictive value, positive predictive value and accuracy of SLNB in oral cancer Timepoint: 24 months;To compare the lymphoscintigraphic detection with intraoperative detection of SLNB using gamma camera Timepoint: 24 months;To determine the identification rate of SLNB in early oral cavity cancer Timepoint: 24 months | — |
Countries
India
Contacts
AIIMS Rishikesh